Previous studies have found patients with multiple myeloma have lower CD4+ T/CD8+ T ratios relative to healthy donors and these ratios are further decreased in ISS stage 3 versus ISS stage 1 patients (5). The gene discussed is CD4; the disease is plasma cell myeloma.